½ÃÀ庸°í¼­
»óÇ°ÄÚµå
1556216

¼¼°èÀÇ º§ ¸¶ºñ Ä¡·á ½ÃÀå º¸°í¼­(2024³â)

Bell¢¥s Palsy Treatment Global Market Report 2024

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: The Business Research Company | ÆäÀÌÁö Á¤º¸: ¿µ¹® 175 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

º§ ¸¶ºñ Ä¡·á ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¼ö³â°£ °­·ÂÇÑ ¼ºÀåÀÌ Àü¸ÁµË´Ï´Ù. 2028³â¿¡´Â CAGR 5.2%·Î 30¾ï 7,000¸¸ ´Þ·¯·Î ¼ºÀåÇÕ´Ï´Ù. ¿¹Ãø ±â°£ Áß ¿¹»óµÇ´Â ¼ºÀåÀº º§ ¸¶ºñ¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, »óȯ Á¤Ã¥ÀÇ ¹ßÀü, ¸é¿ª·Â ÀúÇÏ·Î ÀÎÇÑ ¹ÙÀÌ·¯½º °¨¿°ÀÇ À¯º´·ü Áõ°¡, °Ç°­¿¡ ÇØ·Î¿î »ýÈ° ½À°ü Áõ°¡, ÁÖ¿ä Á¦¾à ȸ»çÀÇ ÁýÁß µî ¿©·¯ °¡Áö ¿äÀο¡ ±âÀÎÇÕ´Ï´Ù. ÀÌ ±â°£¿¡ ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµÇ´Â ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ¿¬±¸°³¹ß¿¡ ´ëÇÑ ÅõÀÚ, ´ú ħ½ÀÀûÀÎ »õ·Î¿î Ä¡·á ±â¼ú °³¹ß, ±Í¿Í ´«ÀÇ °¨¿° À¯º´·ü Áõ°¡, Áúº´¿¡ ´ëÇÑ »çȸÀû ÀÎ½Ä Áõ°¡, º§ ¸¶ºñ Ä¡·á¿¡ ƯȭµÈ ½ÂÀÎµÈ ¾à¹°ÀÇ ºÎÁ· µîÀÌ ÀÖ½À´Ï´Ù.

¹ÙÀÌ·¯½º °¨¿°ÁõÀÇ À¯º´·ü Áõ°¡´Â º§ ¸¶ºñ Ä¡·á ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¹ÙÀÌ·¯½º °¨¿°Àº »ì¾ÆÀÖ´Â ¼¼Æ÷¿¡ ħÀÔÇÏ¿© ¹ø½ÄÇÏ´Â ¹ÙÀÌ·¯½º¿¡ ÀÇÇØ ¹ß»ýÇϴµ¥, Àü ¼¼°è ¿©Çà, µµ½ÃÈ­, ±âÈÄ º¯È­ µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ ¹ÙÀÌ·¯½ºÀÇ È®»ê°ú º¯ÀÌ°¡ ÃËÁøµÇ¾î ´õ ÈçÇØÁö°í ÀÖ½À´Ï´Ù. º§ ¸¶ºñ Ä¡·á¿¡´Â ¿°ÁõÀ» ¾ïÁ¦ÇÏ´Â ºÎ½ÅÇÇÁú ½ºÅ×·ÎÀ̵åÁ¦³ª ¹ÙÀÌ·¯½º¼º ¿øÀÎÀÌ ÀǽɵǴ °æ¿ì ¾Æ½ÃŬ·Î¹ö, ¹ß¶ó½ÃŬ·Î¹ö¿Í °°Àº Ç×¹ÙÀÌ·¯½ºÁ¦°¡ Æ÷ÇԵǴ °æ¿ì°¡ ¸¹À¸¸ç, ¾È¸é±ÙÀ° ±â´ÉÀÇ °³¼±°ú ȸº¹À» ¸ñÀûÀ¸·Î ÇÕ´Ï´Ù. ¿¹¸¦ µé¾î 2023³â 11¿ù ¹Ì±¹ Áúº´¿¹¹æÅëÁ¦¼¾ÅÍ´Â 2021-2022³â µ¶°¨ ½ÃÁ𠵿¾È µ¶°¨ °¨¿°ÀÚ ¼ö 900¸¸ ¸í, µ¶°¨ °ü·Ã Áø·á ȯÀÚ ¼ö 400¸¸ ¸í, µ¶°¨ °ü·Ã ÀÔ¿ø ȯÀÚ ¼ö 10¸¸ ¸í, µ¶°¨À¸·Î ÀÎÇÑ »ç¸ÁÀÚ ¼ö°¡ 5,000¸íÀ̶ó°í º¸°íÇß½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ÙÀÌ·¯½º °¨¿°ÁõÀÇ È®»êÀº º§¸¶ºñ Ä¡·áÁ¦ ½ÃÀå È®´ë¿¡ ±â¿©ÇÏ°í ÀÖ½À´Ï´Ù.

º§ ¸¶ºñ Ä¡·á ½ÃÀåÀÇ ÁÖ¿ä ¾÷üµéÀº ÅëÇÕ Ä¡·á¸¦ Á¦°øÇÏ°í ȯÀÚ °á°ú¸¦ °³¼±Çϸç Ä¡·á °úÁ¤À» °£¼ÒÈ­Çϱâ À§ÇØ ¾È¸é ½Å°æ ¸¶ºñ Ä¡·á ¼¾Å͸¦ ¼³¸³ÇÏ´Â µ¥ ÁÖ·ÂÇÏ°í ÀÖ½À´Ï´Ù. ¾È¸é½Å°æ¸¶ºñ Ä¡·á¼¾ÅÍ´Â ¾È¸é½Å°æ¸¶ºñ ȯÀÚÀÇ Áø´Ü, Ä¡·á, ÀçÈ°À» Àü¹®À¸·Î ÇÏ´Â Àü¹® ½Ã¼³ÀÔ´Ï´Ù. ¿¹¸¦ µé¾î 2023³â 7¿ù Àεµ¿¡ À§Ä¡ÇÑ ´ÙÇÐÁ¦ Àü¹®º´¿øÀÎ »çÄí¶ó ¿ùµå º´¿øÀº ¾È¸é½Å°æ¸¶ºñ Àü¹® Ä¡·á¸¦ Á¦°øÇÏ´Â Á¾ÇÕ ¾È¸é½Å°æ¸¶ºñ Ä¡·á¼¾Å͸¦ °³¼ÒÇß½À´Ï´Ù. ÀÌ ¼¾ÅÍ´Â ½Å°æ°ú Àü¹®ÀÇ, ¼ºÇü¿Ü°ú Àü¹®ÀÇ, ¹°¸®Ä¡·á»ç, ¾ð¾îÄ¡·á»ç°¡ Âü¿©ÇÏ´Â ´ÙÇÐÁ¦Àû Á¢±Ù¹ýÀ» ÅëÇØ º§¸¶ºñ, ¼±Ãµ¼º ¾È¸é¸¶ºñ, ¾È¸é½Å°æ¼Õ»ó µî ´Ù¾çÇÑ À¯ÇüÀÇ ¾È¸é½Å°æ¸¶ºñ¸¦ °ü¸®ÇÏ°í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå ½ÃÀåÀÇ Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

  • °íÀÎÇ÷¹À̼ÇÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâ
  • ¿ìÅ©¶óÀ̳ª¡¤·¯½Ã¾Æ ÀüÀïÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâ
  • ½ÃÀå¿¡ ´ëÇÑ COVID-19ÀÇ ¿µÇâ

Á¦5Àå ¼¼°è ½ÃÀå ±Ô¸ð¿Í ¼ºÀå

  • ¼¼°èÀÇ º§ ¸¶ºñ Ä¡·á ½ÃÀå : ÃËÁø¿äÀΰú ¾ïÁ¦¿äÀÎ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ¼¼°èÀÇ º§ ¸¶ºñ Ä¡·á ½ÃÀå ½ÇÀû : ±Ô¸ð¿Í ¼ºÀå, 2018-2023
  • ¼¼°èÀÇ º§ ¸¶ºñ Ä¡·á ½ÃÀå ¿¹Ãø : ±Ô¸ð¿Í ¼ºÀå, 2023-2028, 2033F

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

  • ¼¼°èÀÇ º§ ¸¶ºñ Ä¡·á ½ÃÀå : Áø´Üº°, ½ÇÀû°ú ¿¹Ãø, 2018-2023, 2023-2028F, 2033F
  • ÀÚ±â°ø¸í¿µ»ó(MRI)
  • ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ(CT) ½ºÄµ
  • ±ÙÀüµµ °Ë»ç
  • ¼¼°èÀÇ º§ ¸¶ºñ Ä¡·á ½ÃÀå : Ä¡·áº°, ½ÇÀû°ú ¿¹Ãø, 2018-2023, 2023-2028F, 2033F
  • ¾à
  • ¹°¸® Ä¡·á
  • ¼ö¼ú
  • ¼¼°èÀÇ º§ ¸¶ºñ Ä¡·á ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°, ½ÇÀû°ú ¿¹Ãø, 2018-2023, 2023-2028F, 2033F
  • º´¿ø
  • Àü¹® Ŭ¸®´Ð

Á¦7Àå Áö¿ªº°¡¤±¹°¡º° ºÐ¼®

  • ¼¼°èÀÇ º§ ¸¶ºñ Ä¡·á ½ÃÀå : Áö¿ªº°, ½ÇÀû°ú ¿¹Ãø, 2018-2023, 2023-2028F, 2033F
  • ¼¼°èÀÇ º§ ¸¶ºñ Ä¡·á ½ÃÀå : ±¹°¡º°, ½ÇÀû°ú ¿¹Ãø, 2018-2023, 2023-2028F, 2033F

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

  • º§ ¸¶ºñ Ä¡·á ½ÃÀå : °æÀï ±¸µµ
  • º§ ¸¶ºñ Ä¡·á ½ÃÀå : ±â¾÷ °³¿ä
    • Pfizer Inc.
    • Johnson & Johnson
    • Merck & Co. Inc.
    • AbbVie Inc.
    • Bayer AG

Á¦31Àå ±âŸ ´ë±â¾÷°ú Çõ½ÅÀû ±â¾÷

  • Sanofi SA
  • Bristol-Myers Squibb and Company
  • AstraZeneca
  • Abbott Laboratories
  • Novartis AG
  • GlaxoSmithKline PLC
  • Roche Holding AG
  • Takeda Pharmaceutical Company Limited
  • Eli Lily and Company
  • Gilead Sciences Inc.
  • Siemens Healthcare GmbH
  • Teva Pharmaceutical Industries Ltd.
  • Regeneron Pharmaceuticals Inc.
  • Biogen Inc.
  • Astellas Pharma Inc.

Á¦32Àå °æÀï º¥Ä¡¸¶Å·

Á¦33Àå °æÀï ´ë½Ãº¸µå

Á¦34Àå ÁÖ¿ä ÇÕº´°ú Àμö

Á¦35Àå ÇâÈÄ Àü¸Á°ú ÀáÀçÀû ºÐ¼®

Á¦36Àå ºÎ·Ï

KSA 24.09.30

Bell's Palsy treatment encompasses medical and therapeutic approaches designed to manage and alleviate the symptoms of Bell's Palsy, which is characterized by sudden, temporary weakness or paralysis of the facial muscles on one side of the face. The goal of treatment is to reduce inflammation, alleviate pain, protect the eye, and improve muscle function, often involving medications and supportive care.

The primary diagnostic methods for Bell's Palsy include magnetic resonance imaging (MRI), computed tomography (CT) scans, and electromyography. MRI is a non-invasive imaging technique that utilizes powerful magnets and radio waves to create detailed images of internal structures. Treatment options consist of medication, physical therapy, and, in some cases, surgery. These treatments are typically administered in hospitals and specialty clinics.

The bell's palsy treatment market research report is one of a series of new reports from The Business Research Company that provides bell's palsy treatment market statistics, including bell's palsy treatment industry global market size, regional shares, competitors with a bell's palsy treatment market share, detailed bell's palsy treatment market segments, market trends and opportunities, and any further data you may need to thrive in the bell's palsy treatment industry. This bell's palsy treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The bell's palsy treatment market size has grown strongly in recent years. It will grow from $2.38 billion in 2023 to $2.50 billion in 2024 at a compound annual growth rate (CAGR) of 5.1%. The growth observed during the historic period can be attributed to several factors, increasing demand for minimally invasive procedures, rising government support, a growing need for technologically advanced treatments, heightened awareness of health and new treatment options, and a rising prevalence of ear and eye infections.

The bell's palsy treatment market size is expected to see strong growth in the next few years. It will grow to $3.07 billion in 2028 at a compound annual growth rate (CAGR) of 5.2%. The anticipated growth during the forecast period can be attributed to several factors, increased awareness of Bell's Palsy, advancements in reimbursement policies, a higher prevalence of viral infections due to weakened immunity, rising unhealthy lifestyles, and significant focus from leading pharmaceutical companies. Key trends expected to influence this period include investment in research and development, the creation of less invasive and novel treatment technologies, a growing prevalence of ear and eye infections, enhanced public awareness of the disease, and a lack of approved drugs specifically for Bell's Palsy treatment.

The increasing prevalence of viral infections is anticipated to drive growth in the bell's palsy treatment market. Viral infections, caused by viruses that invade living cells to reproduce, are becoming more common due to factors such as global travel, urbanization, and climate change, which aid in the spread and mutation of viruses. Bell's palsy treatment often includes corticosteroids to reduce inflammation and antiviral medications such as acyclovir or valacyclovir when a viral cause is suspected, with the goal of improving facial muscle function and recovery. For example, in November 2023, the Centers for Disease Control and Prevention reported that during the 2021-2022 flu season, there were 9 million flu cases, 4 million flu-related medical visits, 100,000 flu-related hospitalizations, and 5,000 flu deaths. This growing prevalence of viral infections is contributing to the expansion of the bell's palsy treatment market.

Key players in the bell's palsy treatment market are focusing on establishing facial palsy care centers to offer integrated care, improve patient outcomes, and streamline treatment processes. A facial palsy care center is a specialized facility dedicated to diagnosing, treating, and rehabilitating individuals with facial paralysis. For instance, in July 2023, Sakra World Hospital, a multi-specialty hospital based in India, opened a Comprehensive Facial Palsy Care Center to provide specialized treatment for facial paralysis. The center employs a multidisciplinary approach, involving neurologists, plastic surgeons, physiotherapists, and speech therapists, to manage various types of facial paralysis, including Bell's palsy, congenital facial palsy, and facial nerve injuries.

In March 2021, Fujifilm Corporation, a Japan-based provider of imaging and information solutions, acquired Hitachi Ltd.'s diagnostic imaging business for JPY 179 billion ($1.14 billion). This acquisition included Hitachi's diagnostic imaging-related business, such as CT, MRI, X-ray, and ultrasound systems, aiming to bolster Fujifilm's medical systems division. Hitachi Ltd., also based in Japan, provided imaging equipment used in diagnosing bell's palsy.

Major companies operating in the bell's palsy treatment market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi SA, Bristol-Myers Squibb and Company, AstraZeneca, Abbott Laboratories, Novartis AG, GlaxoSmithKline PLC, Roche Holding AG, Takeda Pharmaceutical Company Limited, Eli Lily and Company, Gilead Sciences Inc., Siemens Healthcare GmbH, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Astellas Pharma Inc., Sun Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Aurobindo Pharma, Cipla Inc., Lupin Limited, Zydus Lifesciences Limited, Glenmark Pharmaceuticals Limited

North America was the largest region in the bell's palsy treatment market in 2023. The regions covered in the bell's palsy treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the bell's palsy treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bell's palsy treatment market consists of revenues earned by entities by providing services such as facial exercises, massage therapy, and counseling services. The market value includes the value of related goods sold by the service provider or included within the service offering. The bell's palsy treatment market also includes sales of prednisone, acyclovir, valacyclovir, and eye ointments. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bell's Palsy Treatment Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bell's palsy treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bell's palsy treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bell's palsy treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Diagnosis: Magnetic Resonance Imaging (MRI); Computed Tomography (CT) Scan; Electromyography
  • 2) By Treatment: Medication; Physical Therapy; Surgery
  • 3) By End-User: Hospital; Specialty Clinics
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Merck & Co. Inc.; AbbVie Inc.; Bayer AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Bell's Palsy Treatment Market Characteristics

3. Bell's Palsy Treatment Market Trends And Strategies

4. Bell's Palsy Treatment Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Bell's Palsy Treatment Market Size and Growth

  • 5.1. Global Bell's Palsy Treatment Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Bell's Palsy Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Bell's Palsy Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Bell's Palsy Treatment Market Segmentation

  • 6.1. Global Bell's Palsy Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Magnetic Resonance Imaging (MRI)
  • Computed Tomography (CT) Scan
  • Electromyography
  • 6.2. Global Bell's Palsy Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Medication
  • Physical Therapy
  • Surgery
  • 6.3. Global Bell's Palsy Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital
  • Specialty Clinics

7. Bell's Palsy Treatment Market Regional And Country Analysis

  • 7.1. Global Bell's Palsy Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Bell's Palsy Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Bell's Palsy Treatment Market

  • 8.1. Asia-Pacific Bell's Palsy Treatment Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Bell's Palsy Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Bell's Palsy Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Bell's Palsy Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Bell's Palsy Treatment Market

  • 9.1. China Bell's Palsy Treatment Market Overview
  • 9.2. China Bell's Palsy Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Bell's Palsy Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Bell's Palsy Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Bell's Palsy Treatment Market

  • 10.1. India Bell's Palsy Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Bell's Palsy Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Bell's Palsy Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Bell's Palsy Treatment Market

  • 11.1. Japan Bell's Palsy Treatment Market Overview
  • 11.2. Japan Bell's Palsy Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Bell's Palsy Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Bell's Palsy Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Bell's Palsy Treatment Market

  • 12.1. Australia Bell's Palsy Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Bell's Palsy Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Bell's Palsy Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Bell's Palsy Treatment Market

  • 13.1. Indonesia Bell's Palsy Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Bell's Palsy Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Bell's Palsy Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Bell's Palsy Treatment Market

  • 14.1. South Korea Bell's Palsy Treatment Market Overview
  • 14.2. South Korea Bell's Palsy Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Bell's Palsy Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Bell's Palsy Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Bell's Palsy Treatment Market

  • 15.1. Western Europe Bell's Palsy Treatment Market Overview
  • 15.2. Western Europe Bell's Palsy Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Bell's Palsy Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Bell's Palsy Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Bell's Palsy Treatment Market

  • 16.1. UK Bell's Palsy Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Bell's Palsy Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Bell's Palsy Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Bell's Palsy Treatment Market

  • 17.1. Germany Bell's Palsy Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Bell's Palsy Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Bell's Palsy Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Bell's Palsy Treatment Market

  • 18.1. France Bell's Palsy Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Bell's Palsy Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Bell's Palsy Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Bell's Palsy Treatment Market

  • 19.1. Italy Bell's Palsy Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Bell's Palsy Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Bell's Palsy Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Bell's Palsy Treatment Market

  • 20.1. Spain Bell's Palsy Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Bell's Palsy Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Bell's Palsy Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Bell's Palsy Treatment Market

  • 21.1. Eastern Europe Bell's Palsy Treatment Market Overview
  • 21.2. Eastern Europe Bell's Palsy Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Bell's Palsy Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Bell's Palsy Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Bell's Palsy Treatment Market

  • 22.1. Russia Bell's Palsy Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Bell's Palsy Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Bell's Palsy Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Bell's Palsy Treatment Market

  • 23.1. North America Bell's Palsy Treatment Market Overview
  • 23.2. North America Bell's Palsy Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Bell's Palsy Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Bell's Palsy Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Bell's Palsy Treatment Market

  • 24.1. USA Bell's Palsy Treatment Market Overview
  • 24.2. USA Bell's Palsy Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Bell's Palsy Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Bell's Palsy Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Bell's Palsy Treatment Market

  • 25.1. Canada Bell's Palsy Treatment Market Overview
  • 25.2. Canada Bell's Palsy Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Bell's Palsy Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Bell's Palsy Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Bell's Palsy Treatment Market

  • 26.1. South America Bell's Palsy Treatment Market Overview
  • 26.2. South America Bell's Palsy Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Bell's Palsy Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Bell's Palsy Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Bell's Palsy Treatment Market

  • 27.1. Brazil Bell's Palsy Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Bell's Palsy Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Bell's Palsy Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Bell's Palsy Treatment Market

  • 28.1. Middle East Bell's Palsy Treatment Market Overview
  • 28.2. Middle East Bell's Palsy Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Bell's Palsy Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Bell's Palsy Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Bell's Palsy Treatment Market

  • 29.1. Africa Bell's Palsy Treatment Market Overview
  • 29.2. Africa Bell's Palsy Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Bell's Palsy Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Bell's Palsy Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Bell's Palsy Treatment Market Competitive Landscape And Company Profiles

  • 30.1. Bell's Palsy Treatment Market Competitive Landscape
  • 30.2. Bell's Palsy Treatment Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Johnson & Johnson
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Merck & Co. Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. AbbVie Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Bayer AG
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Bell's Palsy Treatment Market Other Major And Innovative Companies

  • 31.1. Sanofi SA
  • 31.2. Bristol-Myers Squibb and Company
  • 31.3. AstraZeneca
  • 31.4. Abbott Laboratories
  • 31.5. Novartis AG
  • 31.6. GlaxoSmithKline PLC
  • 31.7. Roche Holding AG
  • 31.8. Takeda Pharmaceutical Company Limited
  • 31.9. Eli Lily and Company
  • 31.10. Gilead Sciences Inc.
  • 31.11. Siemens Healthcare GmbH
  • 31.12. Teva Pharmaceutical Industries Ltd.
  • 31.13. Regeneron Pharmaceuticals Inc.
  • 31.14. Biogen Inc.
  • 31.15. Astellas Pharma Inc.

32. Global Bell's Palsy Treatment Market Competitive Benchmarking

33. Global Bell's Palsy Treatment Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Bell's Palsy Treatment Market

35. Bell's Palsy Treatment Market Future Outlook and Potential Analysis

  • 35.1 Bell's Palsy Treatment Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Bell's Palsy Treatment Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Bell's Palsy Treatment Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óÇ°À» ¼±Åà Áß
»óÇ° ºñ±³Çϱâ
Àüü»èÁ¦